News & Updates

Levels of sex hormone-binding globulin (SHBG) show an inverse relationship with the development of hypertension and change in blood pressure (BP) levels, independent of major risk factors, according to a community-based study.

Following the switch from combination therapy to monotherapy, rheumatoid arthritis (RA) patients with overall lower disease activity (LDA) have higher odds of achieving and remaining in Simplified Disease Activity Index (SDAI) remission/LDA, suggests a study.

In the phase II VELO trial, third-line (3L) treatment with the anti-EGFR* monoclonal antibody (mAb) panitumumab and standard of care (SoC) improved progression-free survival (PFS) in patients with refractory RAS wild-type metastatic colorectal cancer (WT mCRC).

Pancreatic cancer, recognized as a silent yet potent malignancy, stands among the most lethal forms of cancer. Although ranking as the twelfth most prevalent cancer diagnosed globally, it claims the seventh highest fatality rate, with a disappointing 5 to 10 percent 5-year survival rate. [Available at https://www.hopkinsmedicine.org/health/conditions-and-diseases/pancreatic-cancer/pancreatic-cancer-prognosis Accessed on 30 August 2023]  According to the Global Cancer Observatory 2020 (Globocan) report by the WHO, Malaysia had 1,089 new cases of pancreatic cancer, resulting in 1,066 fatalities. Notably, the incidence was calculated at approximately two individuals per 100,000. 

Treatment with retatrutide, the novel agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors, leads to marked reductions in body weight in individuals with obesity, as shown in the results of a phase II trial.